Department of Orthopedic Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Department of Orthopedic Surgery, Inha University Hospital, Incheon, Republic of Korea.
J Bone Joint Surg Am. 2021 Jan 6;103(1):23-29. doi: 10.2106/JBJS.20.00777.
The purpose of this study was to determine whether tolerated weight-bearing in a hard-soled shoe was noninferior to the use of a short leg cast for the treatment of a fifth metatarsal base avulsion fracture, as assessed with use of a 100-mm visual analog scale (VAS) for pain at 6 months after the fracture.
A total of 145 patients were assessed for eligibility. Of these, 96 patients were randomly assigned to either the hard-soled shoe group (46 patients) or the cast group (50 patients). The primary outcome measure was the mean difference on the 100-mm VAS between groups at 6 months after the fracture. Secondary outcome measures included the time to return to preinjury activity and patient-reported satisfaction. Analysis was performed according to both an intention-to-treat basis (i.e., patients were included in the assessment of their assigned treatment arm, even if they crossed over to the other treatment arm prior to completing the 6-month follow-up) and a per-protocol basis (i.e., patients who completed the 6-month follow-up were analyzed according to the treatment they received).
At 6 months after the fracture, the mean 100-mm VAS was 8.6 ± 7.0 mm in the hard-soled shoe group and 9.8 ± 7.3 mm in the cast group (p = 0.41) according to intention-to-treat analysis. The mean difference in 100-mm VAS between the 2 groups was -1.3 mm (95% confidence interval, -4.3 to 1.8 mm). The upper limit of the 95% confidence interval did not exceed the noninferiority margin of 10 mm, indicating that treatment with the hard-soled shoe was noninferior to treatment with the short leg cast. The proportion of patients who reported satisfaction with their treatment was similar between the hard-soled shoe and cast groups (89.5% compared with 87.5%, respectively; p = 0.79), but the time to return to preinjury activity was significantly shorter in the hard-soled shoe group (37.2 ± 14.4 days compared with 43.0 ± 11.1 days in the cast group; p = 0.04). There were no cases of nonunion in either group.
Weight-bearing as tolerated in a hard-soled shoe for a fifth metatarsal base avulsion fracture was noninferior to the use of a short leg cast as assessed with use of a 100-mm VAS at 6 months after the fracture. Patient-reported satisfaction was similar between groups, but the time to return to preinjury activity was shorter in the hard-soled shoe group.
Therapeutic Level I. See Instructions for Authors for a complete description of levels of evidence.
本研究旨在通过使用 100mm 视觉模拟量表(VAS)评估骨折后 6 个月时的疼痛,确定在硬底鞋中耐受负重是否不劣于短腿石膏治疗第五跖骨基底撕脱骨折,作为评估结果。
共有 145 名患者符合入选标准。其中,96 名患者被随机分配到硬底鞋组(46 名患者)或石膏组(50 名患者)。主要结局测量指标为骨折后 6 个月时两组间 100mm VAS 的平均差值。次要结局测量指标包括恢复到受伤前活动的时间和患者报告的满意度。分析根据意向治疗原则(即,即使患者在完成 6 个月随访之前交叉到另一治疗臂,也将其纳入对其分配的治疗臂的评估)和方案治疗原则(即,根据他们接受的治疗分析完成 6 个月随访的患者)进行。
骨折后 6 个月时,硬底鞋组的平均 100mm VAS 为 8.6±7.0mm,石膏组为 9.8±7.3mm(p=0.41),根据意向治疗分析。两组间 100mm VAS 的平均差值为-1.3mm(95%置信区间,-4.3 至 1.8mm)。95%置信区间的上限未超过 10mm 的非劣效性边界,表明硬底鞋治疗不劣于短腿石膏治疗。硬底鞋组和石膏组报告治疗满意度的患者比例相似(分别为 89.5%和 87.5%;p=0.79),但硬底鞋组恢复到受伤前活动的时间明显缩短(37.2±14.4 天,石膏组为 43.0±11.1 天;p=0.04)。两组均无骨不连病例。
在第五跖骨基底撕脱骨折中,在硬底鞋中耐受负重与短腿石膏治疗相比,在骨折后 6 个月时使用 100mm VAS 评估不劣于后者。两组患者报告的满意度相似,但硬底鞋组恢复到受伤前活动的时间更短。
治疗水平 I。有关证据水平的完整说明,请参阅作者说明。